Hayward, CA, United States of America

Yinhong Chen


 

Average Co-Inventor Count = 20.2

ph-index = 6

Forward Citations = 66(Granted Patents)


Company Filing History:


Years Active: 2017-2021

where 'Filed Patents' based on already Granted Patents

12 patents (USPTO):

Title: Yinhong Chen: Innovator in Cardiovascular Treatments

Introduction

Yinhong Chen is a prominent inventor based in Hayward, California, known for his significant contributions to the field of pharmaceuticals. With a total of 12 patents to his name, he has made remarkable advancements in the development of compounds that target the APJ receptor, which plays a crucial role in cardiovascular health.

Latest Patents

Among his latest patents are the "Alkyl substituted triazole compounds as agonists of the APJ Receptor" and "Heteroaryl-substituted triazoles as APJ receptor agonists." These compounds, identified as Formula I and Formula II, along with their pharmaceutically acceptable salts and stereoisomers, are designed to act as agonists of the APJ receptor. They hold potential for treating cardiovascular and other related conditions, showcasing the innovative nature of Chen's work.

Career Highlights

Yinhong Chen has established a successful career at Amgen Inc., where he continues to push the boundaries of pharmaceutical research. His work has not only contributed to the understanding of the APJ receptor but has also paved the way for new therapeutic options in cardiovascular medicine.

Collaborations

Throughout his career, Chen has collaborated with notable colleagues, including Aarif Yusuf Khakoo and Zhihua Ma. These partnerships have enhanced the research and development of innovative compounds, furthering the impact of their collective work in the pharmaceutical industry.

Conclusion

Yinhong Chen's contributions to the field of cardiovascular treatments through his innovative patents and collaborations highlight his role as a leading inventor. His work continues to inspire advancements in medical research and therapeutic development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…